Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last?

Company Overview - Twist Bioscience (TWST) shares increased by 6.6% to close at $39.13, following a notable trading volume, despite a 24.5% loss over the past four weeks [1] - The company reported strong financial results for Q1 of fiscal 2025, which ended on December 31, 2024, potentially driving the recent share price rally [1] Financial Performance - The upcoming quarterly report is expected to show a loss of $0.56 per share, reflecting a year-over-year increase of 29.1% [2] - Revenue is anticipated to reach $91.96 million, marking a 22.1% increase compared to the same quarter last year [2] Earnings Estimates and Stock Movement - The consensus EPS estimate for Twist Bioscience has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [3] - The stock currently holds a Zacks Rank of 2 (Buy), suggesting positive market sentiment [3] Industry Context - Twist Bioscience operates within the Zacks Medical - Biomedical and Genetics industry, where another company, Immatics (IMTX), experienced a 1.1% decline to $4.45, with a monthly return of -14.6% [3] - Immatics has a consensus EPS estimate of -$0.03 for its upcoming report, which represents a 90.6% year-over-year change [4]